News | April 12, 2026
Eli Lilly launches once-daily weight-loss pill Foundayo
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
